S100b Protein Levels in Subretinal Fluid in Rhegmatogenous Retinal Detachment

REFERENCES

• Sharma A, Grigoropoulos V, Williamson TH. Management of primary rhegmatogenous retinal detachment with inferior breaks. Br J Ophthalmol 2004;88:1372–1375.
   PubMed Web of Science ®Google Scholar
• Abraha HD, Butterworth RJ, Bath PM, et al. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997;34 (Pt 4):366–370.
   Google Scholar
• Fassbender K, Schmidt R, Schreiner A et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 1997;148:101–105.
   PubMed Web of Science ®Google Scholar
• Büttner T, Weyers S, Postert T et al. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997;28:1961–1965.
   PubMed Web of Science ®Google Scholar
• Missler U, Wiesmann M, Friedrich C, et al. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997;28:1956–1960.
   PubMed Web of Science ®Google Scholar
• Elting JW, de Jager AE, Teelken AW et al. Comparison of serum S-100 protein levels following stroke and traumatic brain injury. J Neurol Sci 2000;181:104–110.
   PubMed Web of Science ®Google Scholar
• Herrmann M, Vos P, Wunderlich MT, et al. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000;31:2670–2677.
   PubMed Web of Science ®Google Scholar
•  Sen J, Belli A. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 2007;85:1373–1380.
   PubMed Web of Science ®Google Scholar
• Rambotti MG, Giambanco I, Spreca A et al. S100B and S100A1 proteins in bovine retina: their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry. Neuroscience 1999;92:1089–1101.
   Google Scholar
• Azad R, Kumar A, Sharma YR, et al. Modified needle drainage. A safe and efficient technique of subretinal fluid drainage in scleral buckling procedure. Indian J Ophthalmol 2004;52:211–214.
   Google Scholar
• Schäfer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996;21:134–140.
   PubMed Web of Science ®Google Scholar
• Marchi N, Cavaglia M, Fazio V, et al. Peripheral markers of blood-brain barrier damage. Clin Chim Acta 2004;342:1–12.
   PubMed Web of Science ®Google Scholar
• Raabe A, Kopetsch O, Woszczyk A et al. Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor Neurol Neurosci 2003;21:159–169.
   PubMed Web of Science ®Google Scholar
• Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 2009;27:295–302.
   PubMed Web of Science ®Google Scholar
• Poli-de-Figueiredo LF, Biberthaler P, Filho CS et al. Measurement of S-100B for risk classification of victims sustaining minor head injury — first pilot study in Brazil. Clinics 2006;61:41–46.
   PubMedGoogle Scholar
• Sanfilippo F, Li Volti G, Ristagno G et al. Clinical biomarkers in brain injury: a lesson from cardiac arrest. Front Biosci (Schol Ed) 2010;2:623–640.
   Google Scholar
• Oda Y, Tsuruta R, Fujita M et al. Prediction of the neurological outcome with intrathecal high mobility group box 1 and S100B in cardiac arrest victims: A pilot study. Resuscitation 2012; Feb 1: [Epub ahead of print]
   Google Scholar
• Ide T, Kamijo Y, Ide A et al. Elevated S100B level in cerebrospinal fluid could predict poor outcome of carbon monoxide poisoning. Am J Emerg Med 2012;30:222–225.
   PubMed Web of Science ®Google Scholar
• Jung K, Goerdt C, Lange P et al. The use of S100B and Tau protein concentrations in the cerebrospinal fluid for the differential diagnosis of bacterial meningitis: a retrospective analysis. Eur Neurol 2011;66:128–132.
   Google Scholar
• Fujii C, Tokuda T, Ishigami N, et al. Usefulness of serum S100B as a marker for the acute phase of aquaporin-4 autoimmune syndrome. Neurosci Lett 2011;494:86–88.
   PubMed Web of Science ®Google Scholar
• Michetti F, Massaro A, Murazio M. The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 1979;11:171–175.
   PubMed Web of Science ®Google Scholar
• Bartosik-Psujek H, Psujek M, Jaworski J, et al. Total tau and S100b proteins in different types of multiple sclerosis and during immunosuppressive treatment with mitoxantrone. Acta Neurol Scand 2011;123:252–256.
   PubMed Web of Science ®Google Scholar
• Falcone T, Fazio V, Lee C et al. Serum S100B: a potential biomarker for suicidality in adolescents? PLoS ONE 2010;5:e11089.
   PubMed Web of Science ®Google Scholar
• Steiner J, Bogerts B, Schroeter ML, et al. S100B protein in neurodegenerative disorders. Clin Chem Lab Med 2011;49:409–424.
   PubMed Web of Science ®Google Scholar
• Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739–744.
   PubMed Web of Science ®Google Scholar
• Spreca A, Rambotti MG, Rende M et al. Immunocytochemical localization of S-100b protein in degenerating and regenerating rat sciatic nerves. J Histochem Cytochem 1989;37:441–446.
   PubMedGoogle Scholar
• Cochran AJ, Holland GN, Saxton RE et al. Detection and quantification of S-100 protein in ocular tissues and fluids from patients with intraocular melanoma. Br J Ophthalmol 1988;72:874–879.
   Google Scholar
• Quintyn JC, Pereira F, Hellot MF, et al. Concentration of neuron-specific enolase and S100 protein in the subretinal fluid of rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol 2005;243:1167–1174.
   Google Scholar
• Donato R, Sorci G, Riuzzi F et al. S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta 2009;1793:1008–1022.
   PubMed Web of Science ®Google Scholar
• Huttunen HJ, Kuja-Panula J, Sorci G et al. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 2000;275:40096–40105.
   PubMed Web of Science ®Google Scholar
• Pachydaki SI, Tari SR, Lee SE et al. Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 2006;82:807–815.
   PubMed Web of Science ®Google Scholar
• Donato R, Heizmann CW. S100B Protein in the Nervous System and Cardiovascular Apparatus in Normal and Pathological Conditions. Cardiovasc Psychiatry Neurol 2010;2010:929712.
   Google Scholar
• Dieudonné SC, La Heij EC, Diederen R et al. High TGF-β2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2004;45:4113–4118.
   PubMed Web of Science ®Google Scholar
• Wright NT, Cannon BR, Zimmer DB, et al. S100A1: Structure, Function, and Therapeutic Potential. Curr Chem Biol 2009;3:138–145.
   PubMedGoogle Scholar